190 related articles for article (PubMed ID: 12163643)
1. CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.
Rudiger S; Freund SM; Veprintsev DB; Fersht AR
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11085-90. PubMed ID: 12163643
[TBL] [Abstract][Full Text] [Related]
2. Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions.
Walerych D; Olszewski MB; Gutkowska M; Helwak A; Zylicz M; Zylicz A
Oncogene; 2009 Dec; 28(48):4284-94. PubMed ID: 19749793
[TBL] [Abstract][Full Text] [Related]
3. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
Selkirk JK; Merrick BA; Stackhouse BL; He C
Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
[TBL] [Abstract][Full Text] [Related]
4. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
[TBL] [Abstract][Full Text] [Related]
5. The client protein p53 adopts a molten globule-like state in the presence of Hsp90.
Park SJ; Borin BN; Martinez-Yamout MA; Dyson HJ
Nat Struct Mol Biol; 2011 May; 18(5):537-41. PubMed ID: 21460846
[TBL] [Abstract][Full Text] [Related]
6. The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site.
Harris SF; Shiau AK; Agard DA
Structure; 2004 Jun; 12(6):1087-97. PubMed ID: 15274928
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.
Bullock AN; Henckel J; Fersht AR
Oncogene; 2000 Mar; 19(10):1245-56. PubMed ID: 10713666
[TBL] [Abstract][Full Text] [Related]
8. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the p53-rescue drug CP-31398 in vitro and in living cells.
Rippin TM; Bykov VJ; Freund SM; Selivanova G; Wiman KG; Fersht AR
Oncogene; 2002 Mar; 21(14):2119-29. PubMed ID: 11948395
[TBL] [Abstract][Full Text] [Related]
10. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
Blacklock K; Verkhivker GM
J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
[TBL] [Abstract][Full Text] [Related]
11. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
Roiniotis J; Masendycz P; Ho S; Scholz GM
Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
[TBL] [Abstract][Full Text] [Related]
12. Substrate transfer from the chaperone Hsp70 to Hsp90.
Wegele H; Wandinger SK; Schmid AB; Reinstein J; Buchner J
J Mol Biol; 2006 Feb; 356(3):802-11. PubMed ID: 16403523
[TBL] [Abstract][Full Text] [Related]
13. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
[TBL] [Abstract][Full Text] [Related]
14. hsp90: twist and fold.
Richter K; Buchner J
Cell; 2006 Oct; 127(2):251-3. PubMed ID: 17055424
[TBL] [Abstract][Full Text] [Related]
15. Structure and functionality of a designed p53 dimer.
Davison TS; Nie X; Ma W; Lin Y; Kay C; Benchimol S; Arrowsmith CH
J Mol Biol; 2001 Mar; 307(2):605-17. PubMed ID: 11254385
[TBL] [Abstract][Full Text] [Related]
16. Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements.
Shiau AK; Harris SF; Southworth DR; Agard DA
Cell; 2006 Oct; 127(2):329-40. PubMed ID: 17055434
[TBL] [Abstract][Full Text] [Related]
17. CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible.
Pan Y; Ma B; Nussinov R
J Mol Biol; 2005 Jul; 350(3):514-27. PubMed ID: 15946678
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
[TBL] [Abstract][Full Text] [Related]
19. Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.
Butler JS; Loh SN
Biochemistry; 2003 Mar; 42(8):2396-403. PubMed ID: 12600206
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53.
Hagn F; Lagleder S; Retzlaff M; Rohrberg J; Demmer O; Richter K; Buchner J; Kessler H
Nat Struct Mol Biol; 2011 Sep; 18(10):1086-93. PubMed ID: 21892170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
